Sumit Sharma, MD
Retina Specialist · Cleveland, OHNPI 1801025697
Payments from drug & device makers
Across 522 payments — averaging $2906.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$864K
- Gilead$139K
- Eyepoint US, Inc.$114K
- Roche TCRC, Inc.$81K
- Genentech USA, Inc.$66K
- Regeneron Healthcare Solutions, Inc.$45K
- plus $207K from 20 others
Across 29 payments — averaging $892.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$14K
- Regeneron$12K
- Gilead$61
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 132 | $864,239 |
| Gilead | 43 | $138,711 |
| Eyepoint US, Inc. | 76 | $114,426 |
| Roche TCRC, Inc. | 4 | $81,331 |
| Genentech USA, Inc. | 44 | $66,239 |
| Regeneron Healthcare Solutions, Inc. | 23 | $44,866 |
| Astellas Pharma US Inc | 20 | $32,942 |
| Regeneron | 25 | $28,215 |
| F. Hoffmann-la Roche AG | 9 | $27,427 |
| Harrow Eye, LLC | 11 | $21,537 |
| AbbVie(2 entities) | 22 | $18,831 |
| Bausch & Lomb Americas Inc. | 35 | $13,956 |
| AstraZeneca | 1 | $12,600 |
| Merck | 9 | $10,845 |
| Alimera Sciences, Inc. | 19 | $10,579 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $10,280 |
| Apellis Pharmaceuticals, Inc. | 16 | $6,854 |
| Carl Zeiss Meditec USA, Inc. | 5 | $3,803 |
| ANI Pharmaceuticals, Inc. | 5 | $3,084 |
| Astellas Pharma Global Development | 1 | $3,054 |
| Novartis | 3 | $2,112 |
| Carl Zeiss Meditec, Inc. | 2 | $723 |
| Coherus Oncology, Inc. | 1 | $136 |
| Neurotech Pharmaceuticals, Inc. | 1 | $73 |
| Mallinckrodt Enterprises LLC | 1 | $41 |
| Samsara Vision | 1 | $31 |
How this compares
$1,516,938 in reported general payments places this provider in the 95th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Cleveland
- Aleksandra RachitskayaCleveland$2.1M
- Katherine TalcottCleveland$795K
- Phoebe LinCleveland$323K
- Suber HuangCleveland$128K
- Ananth SastryCleveland$44K
- Warren SobolCleveland$5K
- Mark SeralyCleveland$3K
- Abhishek NaiduCleveland$3K
- Mary-Grace ReevesCleveland$2K
- Matthew OhrColumbus$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.